Ironwood Pharmaceuticals IRWD Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Ironwood Pharmaceuticals’s reported figures.
The official record: Ironwood Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's free cash flow?
- Ironwood Pharmaceuticals (IRWD) reported free cash flow of $74.58M in Q4 2025.
- How has Ironwood Pharmaceuticals's free cash flow changed year-over-year?
- Ironwood Pharmaceuticals's free cash flow increased by 390.2% year-over-year, from $15.21M to $74.58M.
- What is the long-term trend for Ironwood Pharmaceuticals's free cash flow?
- Over 3 years (2021 to 2024), Ironwood Pharmaceuticals's free cash flow has grown at a -26.5% compound annual growth rate (CAGR), from $260.66M to $103.41M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.